IL6 and diabetes mellitus: A recent study demonstrated that Lactobacillus casei CCFM419 could protect mice against diabetes involving gut microbiota, in which the levels of the inflammatory markers such as tumor necrosis factor-ɑ and interleukin-6 decreased while intestinal glucagon-like peptide-1 levels increased [57].